Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/d41573-020-00016-0 http://scihub22266oqcxt.onion/10.1038/d41573-020-00016-0 32127666!ä!32127666 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32127666.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Nat+Rev+Drug+Discov 2020 ; 19 (3): 149-150 Nephropedia Template TP {{tp|p=32127666|t=2020. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) |pdf=|usr=}}{{32127666}} gab.com Text Therapeutic options for the 2019 novel coronavirus (2019-nCoV) JO: Nat Rev Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=32127666 #FOAvip ä Twit Text FOAVip Therapeutic options for the 2019 novel coronavirus (2019-nCoV) ????Nat Rev Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=32127666 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32127666 #FOAvip English Wikipedia <ref>{{Cite pmid|32127666}}</ref> Therapeutic options for the 2019 novel coronavirus (2019-nCoV) #MMPMID32127666 Li G; De Clercq E Nat Rev Drug Discov 2020[Mar]; 19 (3): 149-150 PMID32127666show ga ä |*Betacoronavirus/drug effects/genetics/pathogenicity[MESH] |*Drug Repositioning[MESH] |*Nucleosides/pharmacology/therapeutic use[MESH] |*Protease Inhibitors/pharmacology/therapeutic use[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy[MESH] |HIV Infections/drug therapy[MESH] |Hepatitis B/drug therapy[MESH] |Hepatitis C/drug therapy[MESH] |Humans[MESH] |Influenza, Human/drug therapy[MESH] |Interferon-alpha/pharmacology/therapeutic use[MESH] |Middle East Respiratory Syndrome Coronavirus/drug effects/genetics/pathogenicity[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Polyethylene Glycols/pharmacology/therapeutic use[MESH] |Recombinant Proteins/pharmacology/therapeutic use[MESH] |SARS-CoV-2[MESH] |Severe acute respiratory syndrome-related coronavirus/drug effects/genetics/pathogenicity[MESH]Therapeutic options for the 2019 novel coronavirus (2019-nCoV) (epmc).pdf DeepDyve Pubget Overpricing